Literature DB >> 34261110

Neuromodulation in Super-refractory Status Epilepticus.

Ioannis Stavropoulos1, Ho Lim Pak, Antonio Valentin.   

Abstract

SUMMARY: Status epilepticus (SE) is a severe condition that needs immediate pharmacological treatment to tackle brain damage and related side effects. In approximately 20% of cases, the standard treatment for SE does not control seizures, and the condition evolves to refractory SE. If refractory status epilepticus lasts more than 24 hours despite the use of anesthetic treatment, the condition is redefined as super-refractory SE (srSE). sRSE is a destructive condition, potentially to cause severe brain damage. In this review, we discuss the clinical neuromodulation techniques for controlling srSE when conventional treatments have failed: electroconvulsive therapy, vagus nerve stimulation, transcranial magnetic stimulation, and deep brain stimulation. Data show that neuromodulation therapies can abort srSE in >80% of patients. However, no randomized, prospective, and controlled trials have been completed, and data are provided only by retrospective small case series and case reports with obvious inclination to publication bias. There is a need for further investigation into the use of neuromodulation techniques as an early treatment of srSE and to address whether an earlier intervention can prevent long-term complications.
Copyright © 2021 by the American Clinical Neurophysiology Society.

Entities:  

Year:  2021        PMID: 34261110     DOI: 10.1097/WNP.0000000000000710

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  2 in total

Review 1.  Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects.

Authors:  Marta Nowakowska; Muammer Üçal; Marios Charalambous; Sofie F M Bhatti; Timothy Denison; Sebastian Meller; Gregory A Worrell; Heidrun Potschka; Holger A Volk
Journal:  Front Vet Sci       Date:  2022-06-16

2.  Factors associated with mortality in patients with super-refractory status epilepticus.

Authors:  Yi-Ting Fang; Tsung-Lin Lee; Yi-Hsien Tu; Sheng-Hsiang Lin; Miao-Er Chien; Chin-Wei Huang; Kuei-Sen Hsu; Yi-Jen Wu
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.